// App-Quantinova.ai

OP0249 (2022) : CHARACTERISTICS ASSOCIATED WITH POOR COVID-19 OUTCOMES IN PEOPLE WITH PSORIASIS AND SPONDYLOARTHRITIS: DATA FROM THE COVID-19 PsoProtect AND GLOBAL RHEUMATOLOGY ALLIANCE PHYSICIAN-REPORTED REGISTRIES

Researchers

Presenter

  • P. M. Machado

Principal Investigators

  • S. Mahil

  • N. Dand

  • M. Gianfrancesco

  • S. Lawson-Tovey

  • Z. Yiu

  • M. Yates

  • K. Hyrich

  • L. Gossec

  • L. Carmona

  • E. Mateus

  • D. Wiek

  • S. Bhana

  • M. Gore-Massy

  • R. Grainger

  • J. Hausmann

  • P. Sufka

  • E. Sirotich

  • Z. Wallace

  • T. Olofsson

  • C. Lomater

  • N. Romeo

  • D. Wendling

  • T. Pham

  • C. Miceli Richard

  • B. Fautrel

  • L. Silva

  • H. Santos

  • F. R. Martins

  • R. Hasseli

  • A. Pfeil

  • A. Regierer

  • C. Isnardi

  • E. Soriano

  • R. Quintana

  • F. Omura

  • F. Machado Ribeiro

  • M. Pinheiro

  • W. Bautista-Molano

  • D. Alpizar-Rodriguez

  • C. Saad

  • M. Dubreuil

  • N. Haroon

  • L. S. Gensler

  • J. Dau

  • L. Jacobsohn

  • J. Liew

  • A. Strangfeld

  • J. Barker

  • C. E. M. Griffiths

  • P. Robinson

  • J. Yazdany

  • C. Smith

Medical Centers

  • University College London, Centre for Rheumatology Research & MRC Centre for Neuromuscular Diseases, London, United Kingdom

  • German Rheumatism Research Centre, Epidemiology and Health Care Research, Berlin, Germany

  • King's College London Guy's Campus, St. John's Institute of Dermatology, London, United Kingdom

  • King’s College London, Department of Medical & Molecular Genetics, London, United Kingdom

  • University of Manchester, Dermatology Centre, Manchester, United Kingdom

  • King’s College London, Centre for Rheumatic Disease, London, United Kingdom

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • AP-HP, Pitie Salpetriere Hospital, Department of rheumatology, Paris, France

  • Instituto de Salud Musculoesqueletica, Madrid, Spain

  • European Alliance of Associations for Rheumatology (EULAR), People With Arthritis and Rheumatism (PARE), Kilchberg, Switzerland

  • Pfizer Inc, Pfizer Inc, New York, United States of America

  • Lupus Foundation of America, Lupus Foundation of America, Washington DC, United States of America

  • Department of Medicine, University of Otago Wellington, Wellington, New Zealand

  • Harvard Medical School, Division of Rheumatology and Clinical Immunology, Boston, United States of America

  • Healthpartners, Healthpartners, St Paul, United States of America

  • McMaster University, Department of Health Research Methods, Toronto, Canada

  • Harvard Medical School, Division of Rheumatology and Clinical Immunology, Boston, United States of America

  • Lund University, Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden, Lund, Sweden

  • Università degli Studi di Torino, Academic Rheumatology Centre, Turin, Italy

  • ASO Santa Croce e Carle, SSD Reumatologia, Cuneo, Italy

  • Franche-Comté University and University Teaching Hospital, CHRU, Besançon, France

  • Institut Pasteur, Immunoregulation Unit, Paris, France

  • Centro Hospitalar de Trás-os-Montes e Alto Douro (CHTMAD), Department of Rheumatology, Vila Real, Portugal

  • University Hospital Center of Algarve, Department of Rheumatology, Faro, Portugal

  • Justus-Liebig-University Giessen, Department of Rheumatology and Clinical Immunology, Giessen, Germany

  • Jena University Hospital – Friedrich Schiller University Jena, Department of Internal Medicine III, Jena, Germany

  • Argentine Society of Rheumatology, Research Unit, CABA, Argentina

  • Hospital Italiano de Buenos Aires, Internal Medicine, Buenos Aires, Argentina

  • Clínica Omura Medicina Diagnóstica, Clínica Omura Medicina Diagnóstica, São Paulo, Brazil

  • Universidade do Estado do Rio de Janeiro (UERJ), Hospital Universitário Pedro Ernesto, Rio de Janeiro, Brazil

  • Universidade Federal de São Paulo, Hospital São Paulo, São Paulo, Brazil

  • University Hospital Fundacion Santa Fe de Bogotá, Bogotá, Colombia

  • Colegio Mexicano de Reumatología, Research Unit, Mexico City, Mexico

  • Faculdade de Medicina da Universidade de Sao Paulo, Rheumatology Division, Brazil, Sao Paulo, Brazil

  • Boston University, Rheumatology, Boston, United States of America

  • University Health Network, Division of Rheumatology, Toronto, Canada

  • Massachusetts General Hospital - Boston - United States of America

  • University of Queensland School of Medicine, Brisbane, Queensland, Australia

Locations

  • United Kingdom

  • Germany

  • United States

  • France

  • Spain

  • Switzerland

  • New Zealand

  • Canada

  • Sweden

  • Italy

  • Portugal

  • Argentina

  • Brazil

  • Colombia

  • Mexico

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

  • Musculoskeletal

  • Dermatology

  • Nephrology

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

Disease

  • Chronic obstructive pulmonary disease

  • Chronic kidney disease

  • Spondyloarthritis

  • Diabetes

  • Renal disease

  • Hypertension

  • Psoriasis

  • Coronavirus disease

  • Obesity

  • Asthma

  • Solid malignancies

  • Axial spondyloarthritis

Biomarkers

  • Interleukin-23

  • Interleukin 12

  • Janus kinase

Drug/Treatment

  • Glucocorticoid

  • Sulfasalazine

  • Methotrexate

  • leflunomide

  • Apremilast

  • IL-12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved